Fatourechi Vahab
a Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Expert Rev Endocrinol Metab. 2010 May;5(3):359-373. doi: 10.1586/eem.10.2.
Subclinical thyroid dysfunction occurs when peripheral thyroid hormone levels are within the normal laboratory reference range and the serum thyroid-stimulating hormone (TSH or thyrotropin) level is greater than normal (subclinical hypothyroidism) or less than normal (subclinical hyperthyroidism; TSH normal laboratory reference range: 0.3-5.0 mIU/l). For patients with subclinical hypothyroidism (serum TSH levels >10 mIU/l), thyroxine therapy is prescribed if other causes of TSH elevation and transient conditions have been excluded. For serum TSH levels between 5.0 and 10.0 mIU/l, selective therapy should be considered. For patients with sustained subclinical hyperthyroidism (serum TSH levels <0.1 mIU/l), therapy is recommended, especially in older patients. Observation or selective therapy should be considered for patients with serum TSH levels between 0.1 and 0.3 mIU/l.
当外周甲状腺激素水平在实验室正常参考范围内,而血清促甲状腺激素(TSH或促甲状腺素)水平高于正常(亚临床甲状腺功能减退)或低于正常(亚临床甲状腺功能亢进;TSH正常实验室参考范围:0.3 - 5.0 mIU/l)时,就会发生亚临床甲状腺功能障碍。对于亚临床甲状腺功能减退患者(血清TSH水平>10 mIU/l),如果排除了TSH升高的其他原因和短暂性情况,则应给予甲状腺素治疗。对于血清TSH水平在5.0至10.0 mIU/l之间的患者,应考虑选择性治疗。对于持续性亚临床甲状腺功能亢进患者(血清TSH水平<0.1 mIU/l),建议进行治疗,尤其是老年患者。对于血清TSH水平在0.1至0.3 mIU/l之间的患者,应考虑观察或选择性治疗。